Products are developed on Chinese Hamster Overy (CHO) based Mammalian platform using recombinant DNA technology.

Innovative process developed in-house with the Proprietary DNA Vectors having novel genetic elements in-licensed from a Swiss company enable scientific rigor with speed to develop highly-comparable biosimilars.

Having developed the Clone in-house with a well understood characteristics and intricacies of the host system is one of the great strengths enabling Clonz to have the complete control over the manufacturing processes in the future.